A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to Lamivudine
Status:
Completed
Trial end date:
2005-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical research study is to assess the safety and effectiveness of
switching to entecavir compared to continued lamivudine in patients with chronic hepatitis B.